BMP antagonist CHRDL2 enhances the cancer stem cell phenotype and increases chemotherapy resistance in Colorectal Cancer
This study shows that CHRDL2 overexpression in CRC cells enhances chemotherapy resistance and stem-cell properties by boosting DNA repair and WNT signaling.
bioRxiv · Jan 23, 2024Cancer Biology